A B S T R A C T The suppression of erythropoiesis by lymphocytes from patients with a T cell lymphoproliferative syndrome and pure erythrocyte aplasia has been previously demonstrated. To study the nature of the suppressor cell and possible genetic restriction of this suppression, we investigated a patient with severe anemia, splenomegaly, lymphocytosis, and erythroid aplasia. A 3-mo course of low-dose daily oral cyclophosphamide achieved a complete remission for over 12 mo. The surface phenotype of his lymphocytes was analyzed by means of antibodies to lineage, differentiation, and activation-specific surface antigens. The cells expressed mature T cell antigens T3, T8, and Tll, while lacking Ti. Immature T cell, B cell, and the monocyte-specific antigen Mo2 were absent, while Mol, a monocyte-associated antigen not normally expressed on T cells, was present. T1O and Ia expressed as activation antigens were also present. The cells, cryopreserved at diagnosis, were thawed and co-cultured in plasma clot with patient remission marrow samples at T cell/bone marrow ratios of 1:1 and 2:1.
INTRODUCTION
The fine regulation of erythropoiesis is accomplished by both inductive and suppressive mechanisms.
Induction is achieved by a hormone and a less wellcharacterized factor. The hormone, erythropoietin, stimulates the division of mature erythroid progenitors and their terminal differentiation into proerythroblasts (1, 2) , whereas the factor, burst-promoting, or erythroid-potentiating, activity (BPA),' appears to influence the capacity of progenitors, particularly immature progenitors, to respond to erythropoietin. Current evidence suggests that an interaction of T lymphocytes and macrophages leads to the elaboration of BPA (3), whereas erythropoietin is produced in the kidneys of adults (4) .
Suppression of erythropoiesis is regulated by the influence of the level of oxyhemoglobin on erythropoietin production. Recent investigations have additionally suggested the existence of a second suppressive system exerted by T lymphocytes (5, 6) . The existence of such a system was initially suggested by clinical examples of anemia or granulocytopenia associated with an expansion of certain T lymphocyte populations (7) (8) (9) (10) (11) (12) (13) . Furthermore, studies of normal cells have led to the suggestion that T lymphocyte-induced suppression of in vitro erythropoiesis may be genetically restricted (14) . To examine the in vivo relevance of the latter possibility, we studied the effects of the T lymphocytes of a patient with the previously described syndrome of T lymphocytosis and erythrocyte aplasia (7) (8) (9) (10) upon the in vitro erythropoiesis of the patient, his two HLA identical siblings, and a panel of nine partially or totally HLA dissimilar normal individuals. The results show that these cells specifically and uniquely suppress the differentiation of erythroid progenitors that bear genotypically or phenotypically identical HLA antigens. The unique phenotype of these cells suggests the possibility that they may represent an unregulated expansion of a normal subpopulation of T lymphocytes or a malignant clone, the normal cellular counterpart of which is present at low levels and modulates the production of erythrocytes.
METHODS
Case report. R.McQ. is a 32-yr-old man who first presented with anemia, hepatosplenomegaly, and lymphocytosis. Peripheral lymphadenopathy was absent. His hematocrit was 15% with a mean corpuscular volume of 104, a reticulocyte count of 0.9%, and a lymphocyte count of 21,000/mm3. The leukocyte differential showed 11% granulocytes, 4% bands, 2% metamyelocytes, 1% basophils, 80% large lymphocytes, and 2% monocytes. The platelet count was 400,000/mm3. Coombs and heterophile antibody tests were negative. Bone marrow biopsy showed hypercellularity with increased number of myeloid cells and megakaryocytes, but virtually absent erythroid precursors. Occasional cells of an indeterminate type were noted. An exploratory laparotomy was performed and a 580-g spleen was removed. A concomitant liver biopsy was performed. Both the liver and spleen were diffusely infiltrated with large lymphoid cells. After splenectomy, the patient's leukocyte count rose from 20,000 to 35,700/mm3, with 90% lymphocytes. He was then begun on a regimen consisting of vincristine, cyclophosphamide, bleomycin, and prednisone for 10 mo. His hematocrit rose to between 27 and 30%. The leukocyte count was maintained between 18 ,000 and 25,000/mm3, with at least 80% lymphocytes. Treatment was then discontinued for 1 yr, during which time he again developed severe anemia with a hematocrit in the range of 20%. He became transfusion dependent for 8 mo. A repeat bone marrow aspiration showed relative granulocytic hyperplasia, increased megakaryocytes, and minimal lymphoid infiltration. Erythroid precursors were few to absent. At this point, the leukocyte count was in the range of 20,000/mm3 with 80% lymphocytes, nearly all of which resembled the cells shown in Fig.  1 . The patient underwent phlebotomy and -108 of these cells were isolated by Ficoll-Hypaque centrifugation. These were cryopreserved, and the patient was started on 100 mg of cyclophosphamide by mouth for 2 mo. The dose was decreased to 50 mg/d for 2 additional mo. When the hematocrit was noted to be 45%, a bone marrow aspirate showed normal hematopoiesis with no excess of lymphocytes. No further therapy or transfusions were given for 18 mo. As of December 1982, his leukocyte count was -10,000/mm3, with 55% granulocytes, and 31% lymphocytes with no excess of T8 (15) positive cells, 500,000 platelets/mm3, a hematocrit of 47%, and a mean corpuscular volume of 99.
Normal volunteers. 11 informed normal adults, including the two histocompatible male siblings of the patient, consented to provide the bone marrow samples that made this study possible.
HLA typing. Serotyping of cells for HLA A, B, C and DR antigens on the patient and normal controls (Table I) was kindly performed by Ms. K. Shanley (Dana-Farber Cancer Institute HLA Typing Laboratory), using the standard National Institutes of Health cytotoxicity technique on peripheral blood B cells.
Monoclonal antibodies. The preparation and characterization of monoclonal antibodies used in this study has been previously described in detail (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) . All antibodies were ascites fluid and used at saturated binding concentrations. Controls were isotype identical nonreactive ascites.
Indirect immunofluorescence and flow cytometry. Analysis of the reactivity of the patient lymphocytes with monoclonal antibodies was performed with a fluorescence-activated cell sorter (FACS IV; Becton-Dickman FACS Systems, Mountain View, CA). In brief, 1-2 X 106 cells were treated with either 0.1 ml of a 1:500 dilution of the specific monoclonal antibody to be tested or 0.1 ml of a 1:500 dilution of an unreactive control antibody, incubated at 4°C for 30 min, and washed three times. These cells were then reacted with 0.1 ml of a 1:40 dilution of fluorescein-conjugated goat antimouse Ig G/M (Meloy Laboratories, Inc., Springfield, VA), incubated at 4°C for 30 min, washed three times, and analyzed as previously described (25) . Intensity of fluorescence was determined for 10 (26) were plated at a cell density of 5 X 105/ml in the plasma clot culture system previously described (27) and modified (28, 29 (27) . Erythroid colonies in three to six clots were counted and the results expressed as the mean and standard error of the mean of the number of erythroid colonies per 105 cells plated. Erythroid colony-forming units (CFU-E) were enumerated on day 7 and erythroid burst-forming units (BFU-E) on days 11-14, as previously described (29) .
For evaluation of the granulocyte/macrophage colonyforming unit (CFU-G/M), 0.1 ml of NCTC-109 was substituted for NCTC-109 containing erythropoietin. No cell-conditioned medium as a source of colony-stimulating activity was substituted for an additional 0.05 ml of NCTC-109. Colonies were fixed and stained as for erythroid colony evaluation. GFU G/M colonies were enumerated on days 7 and 11-14.
Cytolytic activity: natural killer (NK) and cytotoxic T lymphocyte (CTL) assay. An assay for NK and CTL activity using K562 or JY cells as targets and T8ES cells as effectors at effector (T8ES)-to-target (K562 or JY) ratios of 100, 25, and 4 to 1 were performed as previously described (31) . Activity was measured as percentage of specific release of 51Cr from labeled targets. CTL activity was measured in lectin (concanavalin A)-dependent and independent systems (32) . Assays were performed in triplicate. (20, 21) . It has never been found on T cells (20, 21) , but was readily detectable on this patient's T cells. The myeloid antigen, Mo2 (20) , was not present. In addition, the Ia antigen was present at an antigen density similar to that found on activated T cells (19 Table IV show that T8ES cells have neither NK nor CTL activity.
RESULTS
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DISCUSSION
In six incidences of aregenerative anemia and two cases of neutropenia, some evidence of lymphocytemediated erythroid or granulocyte suppression has been demonstrated in vitro (7-11, 13, 36) . In the study reported here, we describe a patient with lymphocytosis and aregenerative anemia whose T cells were clearly capable of in vitro suppression of erythroid progenitor differentiation, but had no effect on granulocyte/macrophage progenitor development. In addition, the erythroid suppression identified here was genetically restricted, and the suppressor cells possessed a unique cell surface phenotype (T3, T8, Tll, Mol, Ia). We refer to cells that bear this phenotype as T8ES to signify that these are T8-positive erythroid but not granulocyte suppressor cells.
The specific function of T8ES cells was demonstrated by co-culture of these cells with the autologous marrow cells of the patient when he was in cyclophosphamide-induced remission, with the marrow cells of two histocompatible siblings and with the cells of nine additional unrelated individuals. The results clearly establish that T8ES cells uniquely suppressed erythroid but not granulocyte progenitors with a greater effect on the terminal differentiation of CFU-E than BFU-E. Furthermore, as previously observed in T cell-B cell-macrophage interactions (37), the suppression was observed only when the target marrow and T8ES cell population shared HLA antigens. For example, there was virtually no suppression of erythroid colony formation when T8ES cells were incubated with the marrow cells of either of two totally HLA dissimilar individuals. In contrast, erythroid colony formation was equally suppressed by T8ES cells cultured with the marrow cells of the patient, his HLA identical siblings and two unrelated donors with incomplete phenotypic identity at HLA AB and AC, respectively, but with complete identity at DR (DR2/DR4).
To examine whether the suppression was uniquely governed by recognition of class I or class II antigens, we evaluated three individuals phenotypically haploidentical for DR (DR4/DR-), (DR3/DR4), and (DR4/DR7) and found some suppression of CFU-E differentiation and no BFU-E suppression in two of (39) . Therefore, although we sug- The percentage of specific release = 100 X [(E -C)/(T -C)], in which E is counts per minute released by incubating 5'Cr-labeled targets with immune cells (T8ES or control), C is counts per minute released from targets by medium alone, and T is total counts per minute releasable from targets with 100 ;J 5% Triton X-100. Assays were performed in triplicate. Percentage of release < 20 is considered negative. t Concanavalin A (Con A) when added activates CTL and removes HLA and antigen specificity. Cells capable of lectin (Con A)-dependent killing are defined as CTL (32) .
gest that class II antigen recognition is involved in the mechanism of erythroid suppression by T8ES cells, we cannot rule out class I antigen recognition in this system.
Given the fact that the erythroid suppression induced by T8ES cells demands identity at either the DR or HLA A locus, the mechanism of that suppressor function remains obscure. The lack of CFU-G/M colony suppression, the presence of autologous erythroid colony suppression, and the absence of erythroid or myeloid colony suppression in HLA dissimilar individuals indicates that transfusion sensitization is not a likely mechanism of suppression in this case. The inhibitory effect of T8ES cells was not abrogated by the addition of BPA to, the culture, suggesting that suppression was not mediated via an effect of an erythroid inducer cell that produces BPA (42) .
been described in patients with T cell lymphocytosis associated with anemia (7, 9, 10) , neutropenia (12, 13) , anemia with hypogammaglobulinemia (8), thrombocytopenia (44), hypogammaglobulinemia (45), or hypergammaglobulinemia, as well as cases with no obvious functional abnormality (44) . In a recent review of 25 cases, the lymphocytes in T lymphocytosis were found most frequently to be T8+, TV, and Ti- (44) . Antibody-dependent cytotoxicity by the T cells from patients with T lymphocytosis and cytopenias has been reported (12, 44 (14) may belong to this family.
A complex T cell network has been found to regulate the immune response in man (53) and considerable data have implicated what is believed to be a T lymphocyte as an inducer of erythroid differentiation (5, 6, 29, 54, 55) . In addition, normal Ty cells have been shown to suppress in vitro erythroid (6, 36) and granulocyte (56) colony expression. These observations are strengthened by clinical examples, such as the one presented in this report, where anemia or neutropenia is correlated with in vitro inhibition of erythroid (7) (8) (9) (10) or myeloid (11, 13 ) differentiation by such suppressor cells. These in vitro studies and clinical examples support the growing notion that a complex, genetically regulated network of T cells, some with a hybrid phenotype are involved in the regulation of hematopoietic differentiation.
